The Effect of Qigong Relaxation Exercise on Anxiety and Depression Levels in Individuals Diagnosed With Depression Hospitalized in a Psychiatric Clinic
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 70
- Locations
- 2
- Primary Endpoint
- Beck Depression Scale
Study Overview
Brief Summary
Objective: This study was conducted to examine the effect of Qigong relaxation exercises applied in a psychiatric clinic on the anxiety and depression levels of patients diagnosed with depression.
Design: This study was designed as a single-blind, randomized controlled trial. Research Hypotheses H1: State anxiety levels are lower in patients who perform Qigong exercises than in those who do not.
H2: Depression levels are lower in patients who perform Qigong exercises than in those who do not.
The study population consisted of 140 individuals aged 18 years and older diagnosed with depression who were hospitalized at a private psychiatric hospital in Turkey between March 1 and September 1, 2025. In the sample selection, the STAI-I and Beck Depression Scale were administered to the patients by the researchers. Since differences in anxiety and depression levels would affect group homogeneity, patients who scored below 35 on the STAI-I (mild and moderate levels) and between 17 and 30 on the Beck Depression Scale constituted the study sample. The study sample consisted of 70 patients.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •The patient is literate
- •No communication barriers
- •The patient is receiving inpatient treatment at a psychiatric clinic
- •The patient has been diagnosed with depression
- •The patient is over 18 years of age
- •The patient is oriented to the service (at least 24 hours have passed since admission)
- •The patient regularly participates in Qigong practice
Exclusion Criteria
- •The patient has communication difficulties
- •The patient has acute psychotic symptoms
- •The patient is receiving anxiolytic treatment
Outcomes
Primary Outcomes
Beck Depression Scale
Time Frame: 6 weeks
Beck Depression Scale: The Beck Depression Scale was used to measure the level and severity of depressive symptoms. The Beck Depression Scale, which underwent a Turkish validity and reliability study by Hisli in 1988, is a depression rating scale consisting of 21 questions. Individuals mark the statement that best describes how they have felt over the past 15 days, and the total score is calculated by summing the points (0-3) obtained from each response. According to the corresponding score ranges, the scale is evaluated as follows: 1-10 is normal, 11-16 is moderate mood disorder, 17-20 is clinical depression, 21-30 is moderate depression, 31-40 is severe depression, and 41-63 is major depression.
State-Trait Anxiety Inventory
Time Frame: 6 weeks
This scale was developed by Spielberger et al. (1983), and its validity and reliability in Turkish were established by Öner and Le Compte (1985). The scale consists of two parts: the State Anxiety Scale (STAI-I) and the Trait Anxiety Scale (STAI-II). STAI-I examines how an individual feels at a specific time and under specific conditions, while STAI-II determines how an individual feels independently of the situation and conditions they are in. STAI-I form, which consists of 20 statements, was used to measure state anxiety. Respondents rated their level of anxiety on a 4-point (1- 4) intensity scale from not at all tovery much so.
Secondary Outcomes
No secondary outcomes reported
Investigators
Aydan Akkurt Yalçıntürk
Asst. Prof.
Saglik Bilimleri Universitesi